|
|
Home > Healthcare > Pharmaceutical > General Pharmaceutical
Neose Technologies, Inc. - SWOT Analysis
|
| Published Date:
September 2008
Published By:
Datamonitor
Page Count:
23
Order Code:
R313-40538
|
|
|
|
Datamonitor's Neose Technologies, Inc. - SWOT Analysis company profile is the essential source for top-level company data and information. The report examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy.
Neose Technologies (Neose) is a clinical-stage biopharmaceutical company focused on the development of next generation therapeutic proteins through the application of its proprietary technologies, GlycoAdvance and GlycoPEGylation. The company primarily operates in the US. It is headquartered in Horsham, Pennsylvania and employs 50 people. The company recorded revenues of $8.8 million during the financial year (FY) ended December 2007, an increase of 42.4% over 2006. This was primarily due to an increase in revenues under collaborative agreements with Novo Nordisk and BioGeneriX. The operating loss of the company was $37 million during FY2007, compared to an operating loss of $27 million in 2006. The net loss was $28.5 million in FY2007, as against a net loss of $27.1 million in 2006.
Scope of the Report- Provides all the crucial company information required for business and competitor intelligence needs
- Contains a study of the major internal and external factors affecting the company in the form of a SWOT analysis as well as a breakdown and examination of leading product revenue streams
- Data is supplemented with details on the company’s history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available company statement
Reasons to Purchase- Support sales activities by understanding your customers’ businesses better
- Qualify prospective partners and suppliers
- Keep fully up to date on your competitors’ business structure, strategy and prospects
- Obtain the most up to date company information available
|
Similar Products
• Food and Ingredient Trends Addressing Specific Diseases and Other Health Conditions
Published Dec 2008 by Packaged Facts
• Bristol-Myers Squibb Company and the U.S. Pharmaceutical Preparation Manufacturing Industry
Published Nov 2008 by Supplier Relations US, LLC
• Hospira, Inc. and the U.S. Pharmaceutical Preparation Manufacturing Industry
Published Nov 2008 by Supplier Relations US, LLC
• Chattem, Inc. and the U.S. Pharmaceutical Preparation Manufacturing Industry
Published Nov 2008 by Supplier Relations US, LLC
• Allergan, Inc. and the U.S. Pharmaceutical Preparation Manufacturing Industry
Published Nov 2008 by Supplier Relations US, LLC
• West Pharmaceutical Services, Inc. and the U.S. Surgical Appliance and Supplies Manufacturing Industry
Published Nov 2008 by Supplier Relations US, LLC
• Endo Pharmaceuticals Holdings Inc. and the U.S. Pharmaceutical Preparation Manufacturing Industry
Published Nov 2008 by Supplier Relations US, LLC
• Morocco Pharmaceuticals and Healthcare Report Q4 2008
Published Nov 2008 by Business Monitor International
• Algeria Pharmaceuticals and Healthcare Report Q4 2008
Published Nov 2008 by Business Monitor International
• Nigeria Pharmaceuticals and Healthcare Report Q4 2008
Published Nov 2008 by Business Monitor International
|
|
|
|
0 items
